Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss

Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss

US Patent 10732173 · Granted Aug 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of serotonin expression in gut enteroendocrine cells results in conve2021
Methods for producing enteroendocrine cells that make and secrete insulin2020
Inhibition of serotonin expression in gut enteroendocrine cells results in conve2019
Methods for producing enteroendocrine cells that make and secrete insulin2016
G protein-coupled purinergic receptor Gpr17 mediates orexigenic effects of FoxO12016